RT Journal Article
SR Electronic
A1 Shuman, Jill
T1 Preventing GC-Induced Bone Loss in Women with RA
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 51
SP 9
OP 9
DO 10.1177/155989771451005
UL http://mdc.sagepub.com/content/14/51/9.abstract
AB Glucocorticoids (GCs) are a commonly prescribed treatment for patients with rheumatoid arthritis (RA). However, the long-term use of these agents in postmenopausal women is associated with an increased risk of osteoporosis and fracture. Therefore, the prevention of GC-induced osteoporosis has become an important goal in treating women with RA. This article presents data from the now complete randomized, double-blind phase 4 clinical trial, Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-Term Steroids [NCT01287533]